Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Child Neurology, Hospital Universitario Austral, Buenos Aires, Argentina.
Mol Genet Metab. 2017 Dec;122S:41-48. doi: 10.1016/j.ymgme.2017.09.011. Epub 2017 Sep 28.
The mucopolysaccharidosis (MPS) disorders are ultra-rare lysosomal storage disorders associated with progressive accumulation of glycosaminoglycans (GAGs) in cells and tissues throughout the body. Clinical manifestations and progression rates vary widely across and within the different types of MPS. Neurological symptoms occur frequently, and may result directly from brain damage caused by infiltration of GAGs, or develop secondary to somatic manifestations such as spinal cord compression, hydrocephalus, and peripheral nerve entrapment. Management of secondary neurological manifestations often requires surgical correction of the underlying somatic cause. The present review discusses the surgical management of neurological disease in patients with MPS, including diagnostic imaging. Background information is derived from presentations and discussions during a meeting on the brain in MPS, attended by an international group of experts (April 28-30, 2016, Stockholm, Sweden), and additional literature searches.
黏多糖贮积症(MPS)是一种超罕见的溶酶体贮积症,与全身细胞和组织中糖胺聚糖(GAG)的进行性积累有关。不同类型的 MPS 之间以及其内部的临床表现和进展速度差异很大。神经症状经常发生,可能直接源于 GAG 浸润引起的脑损伤,也可能继发于躯体表现,如脊髓压迫、脑积水和周围神经嵌压。继发性神经症状的治疗通常需要对潜在的躯体病因进行手术矫正。本文讨论了 MPS 患者的神经疾病的手术治疗,包括诊断性影像学检查。背景信息来源于 2016 年 4 月 28 日至 30 日在瑞典斯德哥尔摩举行的一次 MPS 脑病变国际专家会议上的演讲和讨论,以及其他文献检索。